Tolvaptan as A treatment for Refractory Cirrhotic Ascites in Japanese population (TARCAJa study)
Not Applicable
Recruiting
- Conditions
- Cirrhotic patients with ascites unresponsive to standard diuretic therapy
- Registration Number
- JPRN-UMIN000020094
- Lead Sponsor
- Mitsui Memorail Hospital Department of Gastroenterology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
Alergy to tolvaptan. Renal failure patients. Diffcult to drink water. Hypernatremia patients. Heptatic encephalopathy patients. Pregnancy. Other patients who doctors judged as not suitable for this study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Alterlation of ascites and hyponatremia
- Secondary Outcome Measures
Name Time Method Overall survival, safty, and changes in parameter